IQVIA Holdings | IQV - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Accenture USD 15.54B 7.67M 2026-03
Agilent USD 1.43B 2M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Cardinal Health USD 62.86B 65.69B 2026-06
Celltrion KRW 119.22B 21.46B 2026-03
Charles River Laboratories USD 2.84B 1.96B 2026-06
Cigna USD 42.62B 410M 2026-06
Cognizant Technology Solutions USD 4.6B 10.46B 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
CVS Health USD 99.37B 3.62B 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Elevance Health USD 44.88B 981M 2026-06
Humana USD 39.51B 1.61B 2026-06
IBM USD 14.72B 18.25B 2026-06
Illumina USD 899M 47M 2026-06
Infosys INR 221.9M 370.48B 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.27B 146.9M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 103.96B 9.5B 2026-06
Mettler Toledo International USD 739.77M 26.57M 2026-06
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pharma Mar EUR 51.01M 8.73M 2026-06
Publicis EUR 7.58B 51M 2026-06
Qiagen NV USD 393.64M 17.95M 2026-06
Quest Diagnostics USD 2.58B 88M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Tilray USD 237.52M 17.34M 2025-09
UnitedHealth USD 104.04B 1.36B 2026-06
Veeva Systems USD 652.94M 43.11M 2026-06
Veradigm USD 188M 61.08M 2022-12
Waters USD 527M 592M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.45B 431.06M 2026-06